More than skin-deep: Aiming high on behalf of psoriasis patients
There is every reason to watch progress in psoriasis research closely; looking more than skin-deep as psoriasis still remains unsatisfactorily treated in nearly half of cases. In addition, like many other skin problems, psoriasis also has a significant number of associated diseases, which are highly troublesome for the individual. Overall a third of patients have moderate-to-severe psoriasis. Plaque psoriasis is the most common form, affecting 80 to 90 per cent of psoriasis patients. Immunologists and clinicians at Boehringer Ingelheim are pursuing new approaches in different clinical trials to address a range of immunological diseases where the need for more effective treatments is still high.